SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Economics of Routine Childhood Hepatitis A Immunization in the United States: The Impact of Herd Immunity
6 references·0 citing·22 second hop
The Economics of Routine Childhood Hepatitis A Immunization in the United States: The Impact of Herd Immunity (2007)The Economics of Routine Childhood Hepati…Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States (2007)Cost-Effectiveness of Routine…Factors Associated With Hepatitis A Vaccination Among Children 24 to 35 Months of Age: United States, 2003 (2006)Factors Associated With Hepat…Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity (2003)Economic Evaluation of Vaccin…Prevention Effectiveness (2002)Prevention EffectivenessPrevention effectiveness : a guide to decision analysis and economic evaluation (1996)Prevention effectiveness : a …Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (2006)Cost-utility of universal hepatitis A vaccination in Canada (2007)Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2008 (2008)Cost-Effectiveness Analyses of Hepatitis A Vaccine (2008)Racial/Ethnic Disparities in Preschool Immunizations: United States, 1996–2001 (2004)National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 Months—United States, 2004 (2005)The Effect of Policy Changes on Hepatitis A Vaccine Uptake in Arizona Children, 1995–2008 (2011)Markov Models in Medical Decision Making (1993)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Dynamic Transmission Modeling (2012)Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5 (2012)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Patient Time Costs Associated With Cancer Care (2007)Productivity Costs of Cancer Mortality in the United States: 2000–2020 (2008)Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009 (2014)An Economic Analysis of the Current Universal 2-dose measles-mumps-rubella Vaccination Program in the United States (2004)To RCT or not to RCT: deciding when ‘more evidence is needed’ for public health policy and practice (2011)The Economic Burden of Intimate Partner Violence in Ecuador: Setting the Agenda for Future Research and Violence Prevention Policies (2013)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1996Prevention effectiveness : a guide to decision analysis and economic evaluation576 cited
  • 2003Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity252 cited
  • 2002Prevention Effectiveness116 cited
  • 2007Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States75 cited
  • 2006Factors Associated With Hepatitis A Vaccination Among Children 24 to 35 Months of Age: United States, 200333 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work